Chris Watters

Vice President, Franchise Head, Neuroscience Business Unit

Chris Watters is a proven marketing and sales leader with a track record of developing and executing strategies to exceed revenue and profit targets in both global organizations and start-ups over the past 20 years. In his role as Vice President, Neuroscience Business Unit, Chris is responsible for driving the strategy and execution of all activities related to the company’s neuroscience product portfolio as well as for developing and implementing long-term strategic growth initiatives for the franchise.

Chris joined Ipsen Canada in August of 2019 as Senior Business Unit Director, Rare Disease and Neuroscience where he successfully led the building of the new Rare Disease business unit for Canada and transformed our existing Neuroscience business unit to deliver accelerated growth. In 2020, he relocated to the U.S. as Senior Director, Neuroscience Marketing.

Prior to joining Ipsen, Chris worked at Cipher Biotech where he was Vice President, Corporate Development. While at Cipher he was instrumental in transforming the organization by driving strategic restructuring of the business, establishing marketing, market access, and business development capabilities. Chris, a pharmacist by training, spent most of his career at GlaxoSmithKline, most recently as Vice President of Sales. He worked in progressively more senior sales and marketing roles at both GSK and Biovail, including Vice President of Marketing, and National Director of Sales. Chris earned both his Bachelor of Pharmacy and Executive MBA from the University of Toronto.

Our mission?

To improve patients’ lives

Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare disease.

Find out more about us or see other members of our leadership team.


Products and partnerships

Our products

Our mission is to improve patients’ lives.

See our products

Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.

See more on partnering

Products and partnerships

What’s happening now?

See the latest
©2022 Ipsen Biopharmaceuticals, Inc. MP-US-000472 June 2022